TOKYO -- Japanese pharmaceutical companies are ramping up investment to build a domestic supply chain for antibiotics, fueled by government subsidies designed to reduce the nation's reliance on China for critical medicines.
Government rolls out subsidies to cut reliance on China for base ingredients

Japanese pharmaceutical companies are investing in new facilities to produce the base ingredients used to make antibiotics. (Photo by Akitoshi Sugiura)
TOKYO -- Japanese pharmaceutical companies are ramping up investment to build a domestic supply chain for antibiotics, fueled by government subsidies designed to reduce the nation's reliance on China for critical medicines.